Conference
Randomized double-blind multi-dose trial of the oral factor-Xa inhibitor DU-176b versus LMW Heparin (Dalteparin) for prevention of venous thromboembolism after total hip replacement
Authors
Raskob G; Cohen A; Eriksson B; Macdonald A; Puskas D; Shi M; Verho M; Weitz J
Volume
29
Pagination
pp. 609-609
Publisher
OXFORD UNIV PRESS
Publication Date
September 1, 2008
Conference proceedings
EUROPEAN HEART JOURNAL
ISSN
0195-668X